What is the official website of MSD in the UK ?

The official website of MSD in the UK is http://www.msd-UK.com.

What is MSD in the UK's cybersecurity risk score?

MSD in the UK has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD in the UK experienced?

According to Rankiteo, MSD in the UK currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD in the UK been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD in the UK has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD in the UK have SOC 2 Type 1 certification ?

According to Rankiteo, MSD in the UK is not certified under SOC 2 Type 1.

Does MSD in the UK have SOC 2 Type 2 certification ?

According to Rankiteo, MSD in the UK does not hold a SOC 2 Type 2 certification.

Does MSD in the UK comply with GDPR ?

According to Rankiteo, MSD in the UK is not listed as GDPR compliant.

Does MSD in the UK have PCI DSS certification ?

According to Rankiteo, MSD in the UK does not currently maintain PCI DSS compliance.

Does MSD in the UK comply with HIPAA ?

According to Rankiteo, MSD in the UK is not compliant with HIPAA regulations.

Does MSD in the UK have ISO 27001 certification ?

According to Rankiteo,MSD in the UK is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD in the UK operate in ?

MSD in the UK operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD in the UK have ?

MSD in the UK employs approximately 445 people worldwide.

Does MSD in the UK own any subsidiaries ?

MSD in the UK presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD in the UK have ?

MSD in the UK's official LinkedIn profile has approximately 33,422 followers.

What is the NAICS classification code for MSD in the UK ?

MSD in the UK is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MSD in the UK have a Crunchbase profile ?

No, MSD in the UK does not have a profile on Crunchbase.

Does MSD in the UK have a LinkedIn profile ?

Yes, MSD in the UK maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msd-in-the-uk.

How many cybersecurity incidents has MSD in the UK experienced ?

As of September 22, 2026, Rankiteo reports that MSD in the UK has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD in the UK have ?

MSD in the UK has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD in the UK faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

MSD in the UK Vendor Cyber Rating & Cyber Score

msd-UK.com

Add Your Compliance Badge

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For

MSD in the UK CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD in the UK

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MU

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD in the UK in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD in the UK in 2026.

Incident Types MU vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD in the UK in 2026.

Incident History - MU (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD in the UK Subsidiaries

MU

Pharmaceutical Manufacturing

Website: http://www.msd-UK.com

Company Size: 1,001-5,000 employees

MSDPharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD LATAMPharmaceutical Manufacturing

MSD Animal HealthPharmaceutical Manufacturing

MSD DeutschlandPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD EspañaPharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD TürkiyePharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD PortugalPharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

Loading…

MSD in the UK Similar Companies

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Loading…

NEWS

MSD in the UK CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 11, 2025 07:00 AM

MSD calls off £1bn UK expansion amid government-big pharma tensions

Merck & Co (MSD) has ditched plans for its £1bn R&D centre in London, UK, while ceasing drug discovery and research efforts across the...

Read Article

September 11, 2025 07:00 AM

Britain defends investment record as Merck scraps labs over pharma environment

Britain defended its record on attracting investment on Thursday after U.S. drugmaker Merck said it was abandoning a new London research...

Read Article

September 05, 2025 07:00 AM

Halozyme Defends Drug Delivery IP In Battle With Merck

Halozyme has denied claims that its patent for an under-the-skin drug delivery system should be nixed, asking a London court to stop Merck...

Read Article

February 11, 2025 08:00 AM

Arsenal Women Raise Awareness Of Cervical Cancer At North London Derby

Some of the leading stars of Arsenal Women will feature in the launch of a cervical cancer public health campaign which will feature in this weekend's North...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-94426

SUMMARY

A vulnerability was determined in xuxueli xxl-job up to 3.5.0. The impacted element is an unknown function of the file /jobgroup/insert. This manipulation of the argument Name causes cross site scripting. The attack can be initiated remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 3.5)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.1

REFERENCES

CVE-2026-94425

SUMMARY

A vulnerability was found in Moore Threads MTT S80 Driver Package 340.150. The affected element is the function sub_140006F0C in the library mtdispkm64.sys of the component IOCTL Handler. The manipulation results in improper privilege management. Attacking locally is a requirement. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 8.8)

cvss2

Base Score: 6.8

Complexity: LOW

AV:L/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-94627

SUMMARY

vLLM Mooncake connector through 0.29.0 fails to properly manage GPU KV cache block ownership when concurrent child requests share a single transfer ID in prefill/decode disaggregated deployments. Attackers can trigger GPU memory exhaustion by submitting completion requests with multiple prompts, causing orphaned KV cache blocks to accumulate until process restart and eventually preventing legitimate requests from executing.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-94626

SUMMARY

vLLM through 0.29.0 fails to validate the tp_size parameter in kv_transfer_params on OpenAI-compatible completion endpoints, allowing attackers to allocate unbounded memory. Attackers can supply arbitrary tp_size values in prefill/decode disaggregated deployments to exhaust memory and trigger kernel OOM-kill of the decode worker process.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-94625

SUMMARY

vLLM through 0.29.0 contains a resource exhaustion vulnerability in MooncakeConnector where rejected prefill requests create ownerless transfer placeholders that are never reclaimed. Attackers can send rejected requests to exhaust sender task pools, causing valid requests to be delayed by up to 480 seconds while health checks continue returning success.

Published

Date2026-09-21

Updated

Date2026-09-21

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

MSD in the UK Vendor Cyber Rating & Cyber Score

MU A.I CyberSecurity Scoring

MSD in the UK CyberSecurity News & History

MU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MU

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MU vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MU (X = Date, Y = Severity)

MSD in the UK Subsidiaries

MU

MSD in the UK Similar Companies

Johnson & Johnson Innovative Medicine

Lonza

Glenmark Pharmaceuticals

AbbVie

Zydus Group

Astellas Pharma

MANKIND PHARMA LTD

MENARINI Group

Parexel

MSD in the UK CyberSecurity News

MSD calls off £1bn UK expansion amid government-big pharma tensions

Britain defends investment record as Merck scraps labs over pharma environment

Halozyme Defends Drug Delivery IP In Battle With Merck

Arsenal Women Raise Awareness Of Cervical Cancer At North London Derby

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

MSD in the UK CyberSecurity News & History

MU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MU

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MU vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MU (X = Date, Y = Severity)

MSD in the UK Subsidiaries

MU

MSD in the UK Similar Companies

Johnson & Johnson Innovative Medicine

Lonza

Glenmark Pharmaceuticals

AbbVie

Zydus Group

Astellas Pharma

MANKIND PHARMA LTD

MENARINI Group

Parexel

MSD in the UK CyberSecurity News

MSD calls off £1bn UK expansion amid government-big pharma tensions

Britain defends investment record as Merck scraps labs over pharma environment

Halozyme Defends Drug Delivery IP In Battle With Merck

Arsenal Women Raise Awareness Of Cervical Cancer At North London Derby

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo